Ceftriaxone
Sodium USP.
Description:
Ceftriaxone
is a board spectrum parenteral third generation cephalosporin antibiotic. The
drug is highly resistant to bacterial beta-lactamase and has a good activity
against many gram-positive and gram-negative aerobic and some anaerobic
bacteria. It inhibits bacterial cell wall synthesis in a manner similar to that
of penicillin.
Indication:
Ceftriaxone
is indicated for the treatment of the following major infections when caused by
susceptible organisms: 1.Renal & urinary tract infection;
2.
Lower respiratory tract infection particularly pneumonia;
3.
Gonococcal infection; 4.Skin, soft tissue, bone & joint infection;
5.Bacterial
meningitis;
6.Serious
bacterial infection e.g. septicemia; 7.ENT infection;
8.Infection
in cancer patients; 9.Prevention of postoperative infection;
10.Pre-operative
prophylaxis of infection associated with surgery;
11.Typhoid
fever.
Dosage
and Administration:
Adult: It is usually given to adults
in a dose of 1 to 2 gm daily as a once daily dose or in two divided doses
depending on the type and severity of infection. In severe infection up to 4 gm
daily may be given. A single intramuscular dose of 250 mg is recommended for
the treatment of uncomplicated gonorrhea in adult. For surgical prophylaxis in
adults, single dose of 1 gm may be administered 0.5 to 2 hours prior to
surgery.
Children: Suggested doses for infants
and children are 50 to 75 mg per kg body weight once a day; for severe
infection up to 80 mg per kg body weight daily may be given.
Neonates: The maximum dose should not
exceed 50 mg per kg; intravenous doses in neonates should be given over 60
minutes.
Duration of Therapy: The
duration of therapy varies according to the course of the diseases be continued
for a minimum of 48-72 hours after the patients has become a febrile or
evidence of bacterial eradication has been obtained.
Side
effect:
Well
tolerated, side effects are relatively infrequent, usually mild and transient.
The most common side
Effects
are gastro-intestinal consisting mainly of loose stool, diarrhea, nausea,
vomiting steatites and
glossitis.
Contra-indication:
Ceftriaxone sodium should not give in patients with a
history of hypersensitivity to cephalosporin antibiotics. It is contraindicated
in premature infants and in full- term infants during the first 6 weeks of life
No comments:
Post a Comment